Krystal Biotech, Inc.

Krystal Biotech is a biotechnology company that develops genetic medicines, which are treatments that work by fixing or replacing faulty genes. The company's main product is VYJUVEK, a genetic medicine approved to treat dystrophic epidermolysis bullosa, a rare genetic skin disease that causes blistering and wounds. Krystal is also testing other genetic medicines to treat conditions including eye problems, cystic fibrosis, and various skin disorders. The company was founded in 2016 and is based in Pittsburgh, Pennsylvania.